Visible Out-of-plane Polarized Luminescence and Electronic Resonance from Black Phosphorus

Autor: Schué, L., Goudreault, F. A., Righi, A., Resende, G. C., Lefebvre, V., Godbout, E., Pimenta, M. A., Côté, M., Francoeur, S., Martel, R.

Black Phosphorus (BP) is unique among layered materials owing to its homonuclear lattice and strong structural anisotropy. While recent investigations on few layers BP have extensively explored the in-plane (a,c) anisotropy, much less attention has b

Externí odkaz: http://arxiv.org/abs/2112.12617

Comprehensive untargeted lipidomic profiling of third generation lentiviral vectors and packaging cells.

Autor: Roberts JA; Department of Chemistry, Carleton University, Ottawa, Canada. jeff.smith@carleton.ca., Godbout E; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada. elgodbout@ohri.ca., Menard JA; Department of Chemistry, Carleton University, Ottawa, Canada. jeff.smith@carleton.ca., Boddy CN; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Canada. Christopher.Boddy@uottawa.ca., Diallo JS; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada. elgodbout@ohri.ca.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada., Smith JC; Department of Chemistry, Carleton University, Ottawa, Canada. jeff.smith@carleton.ca.; Institute of Biochemistry, Carleton University, Ottawa, Canada.; Carleton Mass Spectrometry Centre, Carleton University, Ottawa, Canada.

Publikováno v: Molecular omics [Mol Omics] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.

An In Silico Database for Automated Feature Identification of High-Resolution Tandem Mass Spectrometry ¹³ C-Trimethylation Enhancement Using Diazomethane ( ¹³ C-TrEnDi)-Modified Lipid Data.

Autor: Roberts JA; Department of Chemistry, Carleton University, Ottawa, Ontario K1S 5B6, Canada., Rosales CA; Department of Chemistry, Carleton University, Ottawa, Ontario K1S 5B6, Canada., Wasslen KV; Department of Chemistry, Carleton University, Ottawa, Ontario K1S 5B6, Canada.; Carleton Mass Spectrometry Centre, Carleton University, Ottawa, Ontario K1S 5B6, Canada., Radnoff AS; Department of Chemistry, Carleton University, Ottawa, Ontario K1S 5B6, Canada., Godbout E; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada., Diallo JS; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada., Manthorpe JM; Department of Chemistry, Carleton University, Ottawa, Ontario K1S 5B6, Canada.; Carleton Mass Spectrometry Centre, Carleton University, Ottawa, Ontario K1S 5B6, Canada., Smith JC; Department of Chemistry, Carleton University, Ottawa, Ontario K1S 5B6, Canada.; Carleton Mass Spectrometry Centre, Carleton University, Ottawa, Ontario K1S 5B6, Canada.

Publikováno v: Journal of the American Society for Mass Spectrometry [J Am Soc Mass Spectrom] 2023 Dec 06; Vol. 34 (12), pp. 2722-2730. Date of Electronic Publication: 2023 Nov 06.

Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen.

Autor: Taha Z; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada., Arulanandam R; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada., Maznyi G; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada., Godbout E; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada., Carter-Timofte ME; Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark., Kurmasheva N; Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark., Reinert LS; Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark., Chen A; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada., Crupi MJF; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada., Boulton S; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada., Laroche G; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada., Phan A; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada., Rezaei R; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada., Alluqmani N; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada., Jirovec A; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada., Acal A; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada., Fekete EEF; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada., Singaravelu R; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada., Petryk J; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada., Idorn M; Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark., Potts KG; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada., Todesco H; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada., John C; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada., Mahoney DJ; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada., Ilkow CS; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada., Giguère P; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada., Alain T; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada; Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, Canada., Côté M; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada., Paludan SR; Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark., Olagnier D; Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark., Bell JC; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada., Azad T; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada., Diallo JS; Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada. Electronic address: jsdiallo@ohri.ca.

Publikováno v: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2022 Sep 07; Vol. 30 (9), pp. 2998-3016. Date of Electronic Publication: 2022 May 06.

Changes in nursing team composition and risk of device-associated infection in intensive care units.

Autor: Shah H; Department of Internal Medicine, VCU School of Medicine, Richmond, VA., Srivastava M; VCU Medical Center, Richmond, VA., Roberson A; VCU Medical Center, Richmond, VA., Lockhart S; VCU Medical Center, Richmond, VA., McKinney W; VCU Medical Center, Richmond, VA., Beavers S; VCU Medical Center, Richmond, VA., Knowlson S; VCU Medical Center, Richmond, VA., Currie L; VCU Medical Center, Richmond, VA., Godbout E; Department of Internal Medicine, VCU School of Medicine, Richmond, VA; VCU Medical Center, Richmond, VA., Stevens MP; Department of Internal Medicine, VCU School of Medicine, Richmond, VA; VCU Medical Center, Richmond, VA., Bearman G; Department of Internal Medicine, VCU School of Medicine, Richmond, VA; VCU Medical Center, Richmond, VA., Cooper K; VCU Medical Center, Richmond, VA., Doll M; Department of Internal Medicine, VCU School of Medicine, Richmond, VA; VCU Medical Center, Richmond, VA. Electronic address: Michelle.doll@vcuhealth.org.

Publikováno v: American journal of infection control [Am J Infect Control] 2022 Feb; Vol. 50 (2), pp. 226-228. Date of Electronic Publication: 2021 Sep 17.